MX2012014783A - Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster. - Google Patents

Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.

Info

Publication number
MX2012014783A
MX2012014783A MX2012014783A MX2012014783A MX2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A
Authority
MX
Mexico
Prior art keywords
herpes
relapse
polyethylene glycol
genitalis
zoster
Prior art date
Application number
MX2012014783A
Other languages
English (en)
Spanish (es)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of MX2012014783A publication Critical patent/MX2012014783A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2012014783A 2010-07-08 2011-07-08 Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster. MX2012014783A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (1)

Publication Number Publication Date
MX2012014783A true MX2012014783A (es) 2013-04-03

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014783A MX2012014783A (es) 2010-07-08 2011-07-08 Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186937A1 (en) 2010-07-08 2013-02-28 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
CN104994889B (zh) 2013-02-19 2017-04-26 强生消费者公司 用于改善疤痕组织的外观和形成的方法及组合物
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
TW201825095A (zh) * 2016-11-28 2018-07-16 德商艾庫里斯抗感染治療有限公司 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物
BR112021021972A2 (pt) 2019-05-03 2021-12-21 Hoffmann La Roche Métodos de redução de uma taxa de atividade de hidrólise enzimática, de redução do nível de uma ou mais enzimas hidrolíticas e de redução da degradação de um polissorbato, composições farmacêuticas e composições de porção de anticorpo formulada
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) * 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
AU2008207104A1 (en) 2007-01-17 2008-07-24 Devirex Ag Cyclodextrin formulations
SG186937A1 (en) 2010-07-08 2013-02-28 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
AU2011275458B2 (en) 2014-11-27
RU2643763C2 (ru) 2018-02-05
RS53162B (sr) 2014-06-30
KR20130142992A (ko) 2013-12-30
EP2563374A1 (en) 2013-03-06
RU2013100383A (ru) 2014-08-20
JP2013530208A (ja) 2013-07-25
WO2012004669A1 (en) 2012-01-12
CN103079574B (zh) 2017-04-12
DK2563374T3 (da) 2014-01-20
IL223582A (en) 2017-12-31
CA2803228A1 (en) 2012-01-12
HK1180969A1 (en) 2013-11-01
JP5858994B2 (ja) 2016-02-10
CN103079574A (zh) 2013-05-01
ES2442928T3 (es) 2014-02-14
SG186937A1 (en) 2013-02-28
PT2563374E (pt) 2014-01-23
ZA201300177B (en) 2014-03-26
SI2563374T1 (sl) 2014-01-31
HRP20140135T1 (hr) 2014-03-28
US9814743B2 (en) 2017-11-14
CA2803228C (en) 2019-03-12
AU2011275458A1 (en) 2013-02-28
KR101881175B1 (ko) 2018-07-23
US20130090389A1 (en) 2013-04-11
PL2563374T3 (pl) 2014-04-30
US20180055875A1 (en) 2018-03-01
EP2563374B1 (en) 2013-11-13

Similar Documents

Publication Publication Date Title
MX2012014783A (es) Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.
CR20130247A (es) Compuestos tricíclicos de la pi3k y métodos de uso
GEP20125564B (en) Pyrimidine derivatives as kinase inhibitors
EP3483163A3 (en) Triazolo[4,5-d]pyrimidine derivatives as cb2 receptor antagonists
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MY170878A (en) [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
MX2016002185A (es) Formulacion combinada de dos compuestos antivirales.
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
PH12014501026A1 (en) [1, 2, 3]triazolo[4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
WO2012065139A8 (en) Entpd5 inhibitors
CA2873723A1 (en) Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
EP2557927A4 (en) FUNGICIDAL MIXTURES I WITH CHINAZOLINES
PH12015502178A1 (en) Pyridinylpyrazoloquinoline compound
PH12015502118A1 (en) Pyridin-4-yl derivatives
MX2013008163A (es) Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea.
MX346090B (es) Derivados de pirrolidina usados como inhibidores de catepsina.
AU2013314244A8 (en) Novel inhibitor compounds of phosphodiesterase type 10A
NZ602247A (en) Endoparasiticidal compositions
PH12014502747A1 (en) Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
MX2016003501A (es) Concentrado liquido para la proteccion de composiciones que van a aplicarse topicamente, contra ataque microbiano.
WO2014038881A3 (ko) 피리돈 유도체를 포함하는 단백질 키나제 억제제
UY33590A (es) Sistemas terapeuticos transdermicos con laminas de proteccion inhibidora de la cristalizacion (release liner)
WO2008120766A1 (ja) 鎮痛用組成物

Legal Events

Date Code Title Description
FG Grant or registration